Basic Information
Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on developing drugs to improve the survival and quality of life for cancer patients. Our portfolio includes small molecule kinase inhibitors that suppress key signaling pathways, promoting cancer cell survival and tumor growth.
Verastem, Inc.
Boston,Massachusetts,United States of America
101~500 people
January 01, 2010
info@verastem.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios